NCT04024475 - Prostate Cancer Biobank | Biotech Hunter

Enrollment

1,323

Participants

Timeline

Start Date

November 4, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

November 30, 2029

Conditions

Prostatic Neoplasms

Interventions

OTHER

Observation

Trial Locations (12)

1211

Hôpitaux Universitaires Genève HUG, Geneva

1708

Hopital Fribourgeois HFR, Fribourg

3600

Spital STS AG, Thun

4031

Universitaetsspital-Basel, Basel

4600

Kantonsspital Olten, Olten

5404

Kantonsspital Baden, Baden

6000

Luzerner Kantonsspital, Lucerne

6900

Clinica Luganese, Lugano

7000

Kantonsspital Graubuenden, Chur

9007

Kantonsspital St. Gallen, Sankt Gallen

CH-3010

Inselspital Bern, Bern

CH-2501

Spitalzentrum Biel, Biel

All Listed Sponsors

collaborator

ProteoMediX AG

INDUSTRY

collaborator

Cantonal Hospital of St. Gallen

OTHER

lead

Swiss Cancer Institute

OTHER